Wang, W., & Zhang, X. (2014). Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: A meta-analysis. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Wang, Wei, y Xiulan Zhang. Systemic Adverse Events After Intravitreal Bevacizumab Versus Ranibizumab for Age-related Macular Degeneration: A Meta-analysis. Public Library of Science (PLoS), 2014.
Cita MLA (8a ed.)Wang, Wei, y Xiulan Zhang. Systemic Adverse Events After Intravitreal Bevacizumab Versus Ranibizumab for Age-related Macular Degeneration: A Meta-analysis. Public Library of Science (PLoS), 2014.
Precaución: Estas citas no son 100% exactas.